Guangzhou Innogen (02591) Announces Monthly Share Capital Update

Bulletin Express
2025/12/03

Guangzhou Innogen Pharmaceutical Group Co., Ltd. (02591) reported no change in its total authorized share capital for November 2025. The authorized share capital remained at RMB 456,819,349, comprising 420,285,370 H shares listed on the Stock Exchange and 36,533,979 unlisted shares, both with a par value of RMB 1.

The company indicated that the issued and treasury shares remained unchanged. The total issued H shares continued at 420,285,370, while unlisted shares stood at 36,533,979. No share options, warrants, convertibles, or other arrangements to issue additional shares were disclosed.

The report was submitted on 03 December 2025 by Jin Jin, Joint Company Secretary.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10